Navigation Links
ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies
Date:11/19/2007

BUDAPEST and GRAZ, Austria, November 19 /PRNewswire/ -- ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry (CDLMC) located at Karl-Franzens-University in Graz today announced a scientific collaboration on flow/microwave chemistry research. The project will focus on the application of flow reactors for organic synthesis and the development of novel technologies utilizing ThalesNano's background in continuous processing. ThalesNano and the Christian Doppler Research Association (CDG) will jointly provide financial support for the collaboration.

Dr. Laszlo Urge, CEO of ThalesNano Inc, said "We joined forces with one of the leading research laboratories in Europe for the application of our technologies. This will enable us to jointly develop novel methods and environmentally friendly solutions with our technology. The Christian Doppler Research Association in Austria provides a great example on how to effectively support basic and applied research and innovation. The Christian Doppler Laboratory for Microwave Chemistry under the leadership of Professor C. Oliver Kappe has proven over the last several years how the adaptation of new technologies can impact the development of science and technology in the field of chemistry. We expect that the collaboration results in further innovations."

Professor Kappe, the Director of the CDLMC, commented "We believe that this collaboration with ThalesNano, one of the leading companies involved in flow chemistry instrument and application development will result in the creation of further important technologies, from which the entire chemistry community in both academia and industry could benefit from.

Professor Ferenc Darvas, president and chairman of ThalesNano Inc. said: "This agreement emphasizes that collaborations between academia and industry are essential and can create economically viable results. The Christian Doppler Laboratory for Microwave Chemistry is leading scientific
'/>"/>

SOURCE ThalesNano Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Laboratory at UI plays major role in diagnosing cancer
2. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
3. Epilepsy-induced brain cell damage prevented in the laboratory
4. Story tips from the Department of Energys Oak Ridge National Laboratory, Nov. 2007
5. Genes, brain chemistry may dictate nicotine cravings, says CU-Boulder study
6. Histochemistry is the golden standard in the diagnosis of carcinosarcomas
7. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
8. MU researchers to collaborate on $20 million project
9. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
10. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
11. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., Higher Costs and Crushing Taxes Nail Nation...re-USNewswire/ -- In response to U.S. House passag...ess & Entrepreneurship Council (SBE Council) p...wing statement: ,, "Make no mistake, those vot... creators with higher costs and crushing taxes and...
(Date:11/8/2009)..., Freeze-drying of biopha...s Mississauga, Ontario facility. , ... Thomas Wellner, President and CEO of Therapure Bi...taken delivery of a commercial scale pharmaceutica...l scale freeze drying (lyophilization) available f...
(Date:11/8/2009)..., Nation,s largest network of Hispanic healt...th care reform in 2009 ,, WASHINGTON, Nov. 7 /...of Representatives showed they have heard the voic...Health Care for America Act. Now the Senate must d...l health care reform," said Dr. Jane L. Delgado, P...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care ...engthen Medicare, improve coverage for all America...-- Today, the United States House of Representativ...re reform legislation that would strengthen Medica... companies that prices millions of Americans out o...
(Date:11/7/2009)..., WASHINGTON , Nov. 7 /PRNewswire-USNewswir...or today in support of H.R. 3962, the Affordable H...n the legislation later tonight. Below are the Sp...we all know, is an historic moment for our nation ...leaders of every party and political philosophy --...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...give in to media pressure to give up cigarettes//....lammed critics who pick on her for smoking saying ...te Moss. Said Miller: "With me it's a terrib...e so cool. Why is that? I won't quit my fags." ...
... B.C. Roy Memorial Hospital here last week, laying...are facilities and bringing// back the horrors of ...te-run referral hospital for children. The 2... which are feared to have led to transfusion of HI...
...d clinical research to cure osteoarthritis without...inful condition to walk again, holding// out promi... Said to be the first of its kind in the world,... (Retd) V.G. Vasishta, former head of radio diagno...
...de in the liver from fatty foods that we eat. A ce...ood stream. Some cholesterol is needed to keep the... conditions such as angina, heart attack and strok... smoke, have high blood pressure are diabetic or o...
...ed woman lawyers not to wear veils in courtrooms, ... "You are professionals and should be dressed as ...Khan of the Peshawar High Court told veiled lawyer...rnment of proceedings in other lawyers' cases," sa...
...sed on November 3, 1906. One hundred years after i... on neuroscience, immunology and vaccine research ...develops and progresses. Researchers at the Yerkes... disorder. About 20 million Americans are currentl...
Other Medicine News:Health News:Crib deaths revisit Kolkata hospital, 22 infants die 2Health News:Indian radiologist spearheads cure for osteoarthritis sans surgery 2Health News:Indian radiologist spearheads cure for osteoarthritis sans surgery 3
(Date:11/6/2009)...-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nas...y, November 10, 2009 at 8:30 a.m. EST to discuss t...ss outlook for the remainder of 2009. Ron Bentsur...t the call. Keryx will announce its financial res...ed prior to the call. ,, In order to participat...
(Date:11/6/2009)...e/ -- NexBio Inc., in collaboration with scientist...n (CDC), St. Louis University, and the University ...wo articles in the peer-reviewed journal PLoS ONE....(Fludase ® ) may play a potentially important...emic Influenza A(H1N1) and drug-resistant influenz...
(Date:11/5/2009)...ewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OS...roducts for regenerative healing, today reported f...mber 30, 2009. ,, "During the third quarter of ...w biologic products MagniFuse(TM) Bone Graft, Fac...novative Grafting," said Sam Owusu-Akyaw, Presiden...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8PRA International to Host Audio Conference 55394 1PRA International to Host Audio Conference 55394 2Breakthroughs in Eye Care Products Offer Fresh Approach for Soothing Eyes 55389 1Breakthroughs in Eye Care Products Offer Fresh Approach for Soothing Eyes 55389 2Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 1Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 2Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 3Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 4
...atch, a publishing and,information services compan..., finds that investigative sites are required to l...s. More than 75% of respondents to a recent,Center...on three or more,EDC systems. In addition, a major...training had improved., State of the Clinical Tri...
...d soon after CEA Trial data reports in third quart...ISCO, May 15 VIA Pharmaceuticals,Inc. (Nasdaq: V...lopment of,compounds for the treatment of cardiova...ted patient enrollment in its acute coronary syndr...se 2 trials investigating VIA-2291,the company,s l...
Other Medicine Technology:CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5
Ident-A-Drug Reference 2005
...fic clinical trial activity and drug development u...rom CenterWatch. This highly valuable resource has... of medical breakthroughs on the frontiers of medi...ults, Newly Approved Drugs, Clinical Trials Listin...
Thomson CenterWatch Clinical Trial Listings
Drug Facts - Gold (A to Z Drugs and Drug Interaction)
Medicine Products: